Preparation and characterization of multimodal hybrid organic and inorganic nanocrystals of camptothecin and gold

被引:10
作者
Hollis, Christin P. [1 ]
Dozier, Alan K. [2 ]
Knutson, Barbara L. [3 ]
Li, Tonglei [4 ]
机构
[1] Univ Kentucky, Dept Pharmaceut Sci, Lexington, KY 40506 USA
[2] Univ Kentucky, Electron Microscopy Ctr, Lexington, KY 40506 USA
[3] Univ Kentucky, Dept Chem Engn & Mat Sci, Lexington, KY 40506 USA
[4] Purdue Univ, Coll Pharm, Dept Ind & Phys Pharm, W Lafayette, IN 47907 USA
关键词
Hybrid inorganic-organic; Drug delivery; Camptothecin; Gold nanoparticles; Computed tomography (CT) contrast agent; Cancer therapy and diagnosis; CONTRAST-MEDIA; LYMPH-NODES; NANOPARTICLES; CT; INTERNALIZATION; TOMOGRAPHY; CELLS;
D O I
10.1016/j.apsb.2018.03.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We demonstrate a novel inorganic-organic crystalline nanoconstruct, where gold atoms were imbedded in the crystal lattices as defects of camptothecin nanocrystals, suggesting its potential use as simultaneous agents for cancer therapy and bioimaging. The incorporation of gold, a potential computed tomography (CT) contrast agent, in the nanocrystals of camptothecin was detected by transmission electron microscope (TEM) and further quantified by energy dispersive X-ray spectrometry (EDS) and inductively coupled plasma-optical emission spectrometers (ICP-OES). Due to gold's high attenuation coefficient, only a relatively small amount needs to be present in order to create a good noise-to-contrast ratio in CT imaging. The imbedded gold atoms and clusters are expected to share the same biological fate as the camptothecin nanocrystals, reaching and accumulating in tumor site due to the enhanced permeation and retention (EPR) effect. (C) 2019 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:128 / 134
页数:7
相关论文
共 36 条
[11]   Lipophilic drug derivatives in liposomes [J].
Gulati, M ;
Grover, M ;
Singh, S ;
Singh, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 165 (02) :129-168
[12]   Dual-Functional Alginic Acid Hybrid Nanospheres for Cell Imaging and Drug Delivery [J].
Guo, Rui ;
Li, Rutian ;
Li, Xiaolin ;
Zhang, Leyang ;
Jiang, Xiqun ;
Liu, Baorui .
SMALL, 2009, 5 (06) :709-717
[13]   Gold nanoparticles: a new X-ray contrast agent [J].
Hainfeld, JF ;
Slatkin, DN ;
Focella, TM ;
Smilowitz, HM .
BRITISH JOURNAL OF RADIOLOGY, 2006, 79 (939) :248-253
[14]   The use of gold nanoparticles to enhance radiotherapy in mice [J].
Hainfeld, JF ;
Slatkin, DN ;
Smilowitz, HM .
PHYSICS IN MEDICINE AND BIOLOGY, 2004, 49 (18) :N309-N315
[15]   Liposomal cancer chemotherapy: current clinical applications and future prospects [J].
Harrington, KJ .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2001, 10 (06) :1045-1061
[16]   Openings between defective endothelial cells explain tumor vessel leakiness [J].
Hashizume, H ;
Baluk, P ;
Morikawa, S ;
McLean, JW ;
Thurston, G ;
Roberge, S ;
Jain, RK ;
McDonald, DM .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (04) :1363-1380
[17]   Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment [J].
Hobbs, SK ;
Monsky, WL ;
Yuan, F ;
Roberts, WG ;
Griffith, L ;
Torchilin, VP ;
Jain, RK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (08) :4607-4612
[18]  
Hosoya T, 2000, Radiat Med, V18, P39
[19]   Dyeing crystals [J].
Kahr, B ;
Gurney, RW .
CHEMICAL REVIEWS, 2001, 101 (04) :893-951
[20]   ADVERSE REACTIONS TO IONIC AND NONIONIC CONTRAST-MEDIA - A REPORT FROM THE JAPANESE-COMMITTEE-ON-THE-SAFETY-OF-CONTRAST MEDIA [J].
KATAYAMA, H ;
YAMAGUCHI, K ;
KOZUKA, T ;
TAKASHIMA, T ;
SEEZ, P ;
MATSUURA, K .
RADIOLOGY, 1990, 175 (03) :621-628